159 related articles for article (PubMed ID: 19937728)
1. 2-methoxyestradiol inhibits atorvastatin-induced rounding of human vascular smooth muscle cells.
Yin H; Gui Y; Zheng XL
J Cell Physiol; 2010 Mar; 222(3):556-64. PubMed ID: 19937728
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin inhibits myocardin expression in vascular smooth muscle cells.
Li J; Jiang J; Yin H; Wang L; Tian R; Li H; Wang Z; Li D; Wang Y; Gui Y; Walsh MP; Zheng XL
Hypertension; 2012 Jul; 60(1):145-53. PubMed ID: 22615115
[TBL] [Abstract][Full Text] [Related]
3. Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway.
Fibbi B; Morelli A; Marini M; Zhang XH; Mancina R; Vignozzi L; Filippi S; Chavalmane A; Silvestrini E; Colli E; Adorini L; Vannelli GB; Maggi M
J Androl; 2008; 29(1):70-84. PubMed ID: 17699803
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway.
Li J; Li JJ; He JG; Nan JL; Guo YL; Xiong CM
Cardiovasc Ther; 2010; 28(1):8-14. PubMed ID: 20074254
[TBL] [Abstract][Full Text] [Related]
5. Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators.
Kizu A; Shioi A; Jono S; Koyama H; Okuno Y; Nishizawa Y
J Cell Biochem; 2004 Nov; 93(5):1011-9. PubMed ID: 15389884
[TBL] [Abstract][Full Text] [Related]
6. Statins activate GATA-6 and induce differentiated vascular smooth muscle cells.
Wada H; Abe M; Ono K; Morimoto T; Kawamura T; Takaya T; Satoh N; Fujita M; Kita T; Shimatsu A; Hasegawa K
Biochem Biophys Res Commun; 2008 Oct; 374(4):731-6. PubMed ID: 18671946
[TBL] [Abstract][Full Text] [Related]
7. Statins prevent pulsatile stretch-induced proliferation of human saphenous vein smooth muscle cells via inhibition of Rho/Rho-kinase pathway.
Kozai T; Eto M; Yang Z; Shimokawa H; Lüscher TF
Cardiovasc Res; 2005 Dec; 68(3):475-82. PubMed ID: 16098957
[TBL] [Abstract][Full Text] [Related]
8. Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors.
Rodríguez C; Alcudia JF; Martínez-González J; Guadall A; Raposo B; Sánchez-Gómez S; Badimon L
Cardiovasc Res; 2009 Aug; 83(3):595-603. PubMed ID: 19406911
[TBL] [Abstract][Full Text] [Related]
9. Involvement of microtubules and Rho pathway in TGF-beta1-induced lung vascular barrier dysfunction.
Birukova AA; Birukov KG; Adyshev D; Usatyuk P; Natarajan V; Garcia JG; Verin AD
J Cell Physiol; 2005 Sep; 204(3):934-47. PubMed ID: 15828024
[TBL] [Abstract][Full Text] [Related]
10. 2-Methoxyestradiol blocks the RhoA/ROCK1 pathway in human aortic smooth muscle cells.
Rigassi L; Barchiesi Bozzolo F; Lucchinetti E; Zaugg M; Fingerle J; Rosselli M; Imthurn B; Jackson EK; Dubey RK
Am J Physiol Endocrinol Metab; 2015 Dec; 309(12):E995-1007. PubMed ID: 26487003
[TBL] [Abstract][Full Text] [Related]
11. Physiologic levels of 2-methoxyestradiol interfere with nongenomic signaling of 17beta-estradiol in human breast cancer cells.
Vijayanathan V; Venkiteswaran S; Nair SK; Verma A; Thomas TJ; Zhu BT; Thomas T
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2038-48. PubMed ID: 16609013
[TBL] [Abstract][Full Text] [Related]
12. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion.
Turner NA; Midgley L; O'Regan DJ; Porter KE
J Cardiovasc Pharmacol; 2007 Oct; 50(4):458-61. PubMed ID: 18049315
[TBL] [Abstract][Full Text] [Related]
14. Pleiotropic role of atorvastatin in regulation of human retinal pigment epithelial cell behaviors in vitro.
Wu WC; Lai YH; Hsieh MC; Chang YC; Wu MH; Wu HJ; Chang CW; Wu KY; Kao YH
Exp Eye Res; 2011 Dec; 93(6):842-51. PubMed ID: 21989109
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of ERK1/2 and p38(MAPK) by components of the Rho signaling pathway during sphingosine-1-phosphate-induced smooth muscle cell migration.
Galaria II; Fegley AJ; Nicholl SM; Roztocil E; Davies MG
J Surg Res; 2004 Dec; 122(2):173-9. PubMed ID: 15555614
[TBL] [Abstract][Full Text] [Related]
16. Prostacyclin induction by high-density lipoprotein (HDL) in vascular smooth muscle cells depends on sphingosine 1-phosphate receptors: effect of simvastatin.
González-Díez M; Rodríguez C; Badimon L; Martínez-González J
Thromb Haemost; 2008 Jul; 100(1):119-26. PubMed ID: 18612546
[TBL] [Abstract][Full Text] [Related]
17. Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction.
Sakurada S; Takuwa N; Sugimoto N; Wang Y; Seto M; Sasaki Y; Takuwa Y
Circ Res; 2003 Sep; 93(6):548-56. PubMed ID: 12919947
[TBL] [Abstract][Full Text] [Related]
18. Statins suppress MMP2 secretion via inactivation of RhoA/ROCK pathway in pulmonary vascular smooth muscles cells.
Li M; Li Z; Sun X
Eur J Pharmacol; 2008 Sep; 591(1-3):219-23. PubMed ID: 18619957
[TBL] [Abstract][Full Text] [Related]
19. Low-density lipoproteins impair migration of human coronary vascular smooth muscle cells and induce changes in the proteomic profile of myosin light chain.
Padró T; Peña E; García-Arguinzonis M; Llorente-Cortes V; Badimon L
Cardiovasc Res; 2008 Jan; 77(1):211-20. PubMed ID: 18006454
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane a(2) induces differentiation of human mesenchymal stem cells to smooth muscle-like cells.
Kim MR; Jeon ES; Kim YM; Lee JS; Kim JH
Stem Cells; 2009 Jan; 27(1):191-9. PubMed ID: 18845763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
